throbber
.
`
`.
`
`. '
`
`..
`
`.
`
`·tn.. •.
`. . . ' .•. · .... · .. ·.
`... .................
`.· ' ·~··i';:·.;<~
`*I ME 0\NAOlc\~~''.JeURNAL OF
`~EUROLOGKAL SCIENCES
`tE]OURNAL CANADIEN DES
`~CIENCES NEUROLOGIQUES ·
`
`D'Anvtlle':s Doom - A Neurological Vignette from Historic Halifax
`srep11en F. Bedwell
`late-Lile Migraine Accompaniments as a Cause of Unexplained Transient
`Ischemic Attacks .................................................. c. Miller Fisher
`Postmortem Increases In Gaba Receptor Binding To Membranes of Cat
`· .Central Nervous System .................... Godfrey Tunnlclitl and G. Kair.ll MEJttleson
`Effects of Nocturnal Gamma·Hydroxybutyrate on Sleep/Waking
`Patterns In Narcolepsv·Cataplexy . • . . . . . . . . . . Roger Broughton and Mortimer Mamatak
`Hemispherectomy lor the Treatment of Epilepsy and Behavior Disturbance .. N.o. Amal!
`University of Toronto Neurosurgical Rounds No. 1 ·
`Masslvo Osteolysis In Association With Multiple Cerebrospinal Fluid
`Fistulae _ Harold J. Hoffman, Derek C. Harwood-Nash, T.P. Morley and M Barry Rewcaslle
`Relationships Belwaen Psychological Measuremnnts and Cerebral Organic
`Changos In Alzheimer's Disease ....... 1-1, Merslmy, M.J. Bllli, w. r. Rlum~;~, Allan .1. Fox.
`Hannah Fox, FL. 1-fersch, V.A. Kr!ll, fl.B. PalmAr
`Features of Croutzfoldt-Jakob Dlseasa In Brains of Pationts With Familial
`Demenlla of Alizhelm,er Typo ........................................... MJ. Ball
`The Effect of Variable Duratlen One Hertz lnterferem:e on Kindling . . . . . . . John Gaito
`Hornor's Syndrome, An Unusual Manifestation of
`Multlpfo Sclerosis . . . . . . . . . .. . Colin R. Bamford, Michael s. Smith and William A. Sibley
`Subdural Empyema With Negallve C.T. Scan:
`A Case Report ............. D.J. Wortl.man, w.s. Tucker,. D.C. Finlayson, R.S. McPht'Jdrrm
`and R Gershtiler
`
`Chronic Extradural Hematoma Presontlno
`With Subgaleal Mass ...... Gi/Del't R.C. Otmrrey, Youssef H. Gabriel and Sl!ml~t.V Tatumg
`Hereditary Sunsory Neuropathy: A Case Vfith Pain and
`Temperature Dissociation _ Betll o·anen. A. Jackson, R. rang-Wai, A.J. Lewis. E.A. Atack
`Nollees and Books ............................................................. .
`
`g ,,..
`
`19
`
`23
`33
`
`39
`
`45
`
`51
`59
`
`65
`
`61
`
`71
`
`73
`17
`
`._
`
`Ranbaxy Ex. 1009
`IPR Petition - USP 8, 772,306
`
`

`
`LE .IOU RN/\L CA :--!ADIEN OES SCIE".:CES NEU ROLOGlQUES
`
`Effects of Nocturnal Gamn1a-Hydroxy butyrate on
`Sleep I Waking Patterns in Narcolepsy-Cataplexy
`
`FR llROil(fHION
`
`NT ROD
`
`FEBR R\
`
`

`
`THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
`
`Carskadon, 1976) or 3 hour (Weitzman
`et al.. 1974) "davs" in nol'mal3ubiccts.
`In the COUfliC of th·esc experinlents,
`the sustained
`which have
`involved
`fragmentation of sleep, polysomno(cid:173)
`gt·aphic patterns identical to those
`in narcolepsy have
`rapidly
`found
`emerged. Sleep onset REM periods
`and ol her manifcst<Hions of disso(cid:173)
`ciated sleep, such as multiple epochs of
`so-called "intcnncdiatc sleep" (Barros(cid:173)
`Perreira and Lairy, l 9'76), appeared
`within a few hours. A !though the full
`clinical syndrome wa.s never elicited, it
`is concci'o,.able that this might have
`to
`it been possible
`occurred had
`~:ontinue these studies for longer time~.
`Indeed. the cl.inical and polysomno(cid:173)
`graphic patterns Qf narcolepsy can
`develop in pathological conditions
`such as sleep apnea which arc typ1fied
`fragmentation
`sleep
`hy chronic
`(Guille.mirmult et at., 1976). Narcu~
`lepsy also appears to develop preferen(cid:173)
`tially in other individuals in whom
`l'or
`i~ chronically disrupted.
`sleep
`example, in shift workers or in nurses
`and doctors whq must keep irregular
`hou.rs in the course of their duties
`ln 50-75% of
`(Broughton, 1971).
`idiopathic cases of narcolepsy-c:ata(cid:173)
`plexy a history of sever~\ sleep depriva(cid:173)
`tion or of irregular sleep habits
`preceded the onset of'the disc;ise, often
`by many years (Mitchell and Dement.,
`!968: Broughton and Ghanem, 1976).
`Moreov~~r. in estab!.ishcd narcoleptics
`the condition characteristically be(cid:173)
`comes llllt!SIIltlly difficult to control
`when there. is any disrupt.ion of the
`sleepjwaking rhythms hy shift work,
`jet lag, 1)r poor sleep habit~ (Broughton,
`1971; Zarcone, !9'73; Broughton &nd
`Ghanem, 1976).
`Although evidence therefore exists
`that. rreceding nocturr111l sleep distur(cid:173)
`bance may have an important mle in
`the genesis or the condition, and
`indeed some authors have included
`ordinary hypnotics .<.Js part of their
`treatment (Daniels, 1934; Zarcone,
`197:5), the major therapeutic appmach
`the daytime
`to suppress
`has heen
`symp·toms ·"sleep attach and drows(cid:173)
`iness with stimulants: and cataplexy
`aux.iliary
`(and other REM-based
`tricyclic or MAO
`symptoms) with
`inhibitory antidepressants.
`We decided to attempt to increase
`the continuity nnd duration or n(JC·
`
`turnal deep and to study the effect of
`thi~ on the symptom~ of the condition.
`To achieve this we have used nocturnal
`doses of gamnta-hydroxybutyratc
`(GHB), a central short chain fatty acid'
`(Doherty ct al., 1976) with hypnotic
`tlropcrtics (Laborit, 1964), We chose
`G H B because it had been shown til
`promote both REM and slpw-wavc
`in
`(Mamclak et aJ., 1977)
`sleep
`contrast to ordinary hypnotics which
`often ~up press these sleep statc.S'(Kale~
`ct al., 1970). GHB also posse~,sed an
`additional major advant<\gc over the
`usu11i hypnotics in that animal studies
`had failed to demonstratt: the develop(cid:173)
`the drug's
`to
`tolerance
`ment of
`hypnotic effects with pro(Qnged use
`(Vickers, 1969}.
`16
`treated
`To dnte, we have
`narcoleptic patients with G f1 B. In a
`preliminary communic:ation concern(cid:173)
`(Broug.hton u 11d
`ing 4 patients
`M<um:lak, !976) and in a companion
`article detailing the clinical asp~.~rts of
`the patients included in the present
`(Broughton and Mamelak,
`report.
`that GliB
`1979), we have shown
`murked!y improves nocturnal sleep
`and that nightmare~. hallucinations,
`and atta("h of sleep paralysis vanish.
`During the day, pressure for sleep
`becomes less imperative and cataplec(cid:173)
`tic attacks become milder and less
`frequent In many patients virtually all
`~ymptorm; of the disease disappear
`when small repeated daily doses of
`stimulants are u~cd in comhination
`with GHB at night. No tolerance ha~
`devdoped so far for this drug regimen,
`nor have there been any serious sltle
`effects, and patients generally find this
`treatment much more palalahle than
`the usual combination of ~timulants
`and tricyclic antidepressant drugs. In
`this papu, we fncus on the effects of
`GHB upon the n:corded sle.cp,!waking
`patterns of our pati1~nts.
`
`PATIENTS AND METHODS
`Fnurteen of the !6 patients (exclud(cid:173)
`technical
`for
`ing nos. 2 and 10,
`reasons), whose histories arc sum(cid:173)
`the previous
`report
`iu
`marized
`(Broughton anti Mamclak, 1979), have
`had complete studies of their 24 hour
`sh.:cp{waking patterns. They consisted
`of seven males and seven l'emal.cs
`betw1:cn the ages nf 21 and 57 (mcun
`
`41.8 ± 13.6). All showed one or several
`slee{) onset REM sleep periods during
`the recordings. Nine of the fourteen
`patients were seriously dcbilitalcd by
`their illness and four had not bcnclitcd
`much fmm the standard trent ments
`combining stimulants <Uld antidt~pres­
`~ant medication. Before starting G H B.
`all previous treatment for narcolepsy
`two
`least
`was dis1.:ontinued for at
`weeks. The pre-trial assessrnent in(cid:173)
`cl.uded a history and physical exami(cid:173)
`renal, and
`nation. hematological,
`hepatic 8tudies. a chest x-ray, ECG,
`EEG, and M MPlund a brief p~ycho­
`logicul assessment, repeated subjective
`assessment of sleepiness using the
`Stanford Skcpiness Scale (Hoddes et
`al., 1973), pupillometry in the Ottawa
`studies, am! baseline pol)'somnogra(cid:173)
`phic recordings. Afterthe investigative
`and purely volun!I.Hy nature of the
`study was expi.:l.lncd, informed and
`signed con~cm was obtained from each
`patient.
`The polysomnographic recordings
`the Ottawa patients (N=7) were
`in
`mude with portahle 4 channel Medilog
`recorders (Oxford Electrical Instm·
`ment Company). This permitted pa(cid:173)
`their normal
`in
`tient monitoring
`environment. and at their usual activity
`levels. The derivations used were C4 -
`t\;, C 1-A 2, a combined horizoma.l(cid:173)
`vertical oculogram ltndi a submental
`EMG. Twenty-four hours of data
`could be recorded <HI one regular C 120
`casscHe .. In the Toronto stltdies, the
`patients (N''7) were hospitalized and
`the recordings obl.ained with a Grass
`rnodel 78B pt)lygraph. None of the
`patients had histories of cxc.essive or
`i nlense snodng ~ugge:~tive. of :sleep
`apnea, and this symptom was formal!.)"
`the Toronto ~tmlies in
`excluded in
`\Vhich a sufficient number of recording
`channels made it possible to monitor
`nasal and thomeic respiration. Con(cid:173)
`tinuous 4B hour recordings of the
`sleep/waking patterns were obtaim~d
`in all patients in the pre-GliB baseline
`period apd then again after 7 to ll'
`nights on the dmg. During the 48
`hour Toronto laboratory recordings.
`lo
`1.11cre encoumged
`the patients
`rernain in bed exc:,t:pt for meals and
`bathroom breuks.
`An initial 1.5 gm to 2.25 grn (I0-15
`ml) dose c•f G H ll was given orally at
`bedtime and followed by one or two
`
`24- FEBRUARY 19!10
`
`Cill/1 and Slcepfwaking l'tmems h1 /'l'arcol .. pY.V
`
`f
`
`[
`t
`(
`(
`~
`[
`! (
`
`f
`(
`~·
`,t
`.4
`
`

`
`LE JOURNAL CAN AD! EN DES SCIENCES NE U ROLOGIQUES
`
`further 1.0 gm to t5 gm doses during
`the night with any major awakening, if
`more th;m 2.5 hours had passed from
`the previous dose. The patients were
`r;:;quired to fc.cl fully alert and clear
`headed before raking their next dose.
`The duration of 0 IH:I's hypnotic effect
`in man is about 2.:5 hours (Mamclak et
`al., 1977), which corresponds closely
`w that of its detectable presence in the
`blood (Hclrich et al., !964). In most
`patients, two or three dose~ were given
`each night in accord with our objective
`of maintaining as continuous a night'.>
`&!eep as possible. GHB was never given
`within two hours of the anticipated
`time of the morning awakening in
`order to avoid hanu-over effects. The
`total qmmtity given ead1 night ranged
`fmrn 3.75g,m to 6.25 gms, correspond(cid:173)
`ing to an <~vcrage patient dosage of
`nhout 50 mg/ kg.
`The polysomnographic data were
`analysed according to international
`uitcria (RechtschE!llcn and Kales,
`J 968) and scored using 40 sec epochs as
`\Vakefulncss, :;tagcs I. 2, 3, 4 and REM
`sh:cp, plus movement lime (MT, i.e.,
`epochs obscured by movement arti(cid:173)
`lacts for over 50% nf their duration
`with pn:vjous ami succeeding epochs
`''ontaining sleep paUcrns). The night
`and daytime portions nf the r~cordings
`were analysed separately. The former
`was arbitmrily defmed ;-u the time
`between the onset of night sleep to the
`time of the final awakt~ning for
`breakfast. Sleep during the rem;~inder
`of the 24 hours was scored as part of
`the daytime (Figs. !. and 2), T'he time of
`sleep onset was taken as the beginning
`of the first continuous 10 min of REM
`or of NREM sleep. ex.clu~ivc of stage
`I, whidl corres1'ondcd to the !Jaticnts's
`subjecti.vc appraisal of sleep onset for
`the night a» sron:d on the SSS forms,
`Si nee no formal bedtime existed in the
`laboratory .~t.ud ies, nor could one be
`e~tabllstu:d in the portable studies, the(cid:173)
`iatcncy from bedtimt: to sleep onset
`was not determined. For each record~
`ing t>eriod, nocturnnl and diurnnL we
`calculated the total sleep times indlld(cid:173)
`ing and exchtding stage ! (which
`corresponds to drowsiness and, most
`authors agree, not to actual sleep).
`Corresponding nocturnal sleep effi(cid:173)
`ciencies refer to the percentages of that
`portion of the recordings occupied by
`the relevant sleep pauerns. Delr.a .,;teep
`
`Broughton & Namdak
`
`Jattmcy was defined as the time front
`sleep onset to the firs! eonUmwus 3 m·
`more min of stage 3 or 4 sleep. REM
`sleep latency was defined as the time
`from the onset of 3 or more min in
`dmation of stage 2 to the first
`continuous 3 or more min of REM
`sleep. If REM sleep occurred before
`stage 2, its latency was determined by
`measuring the interval between the
`bq;inning of the J consecutive. min of
`REM sleep and
`the preceding 3
`con~ccutlve min of wakcfulnes~. REM
`density refers to the percentage of2:;ec
`mini-epochs containi11g one or more
`rapid eye movements. The values
`obtained for each REM period were
`uormali7ed for its durarion and an
`average value for {~ach oft he nocturnal
`and diurnal recording pcric1ds was
`determined.
`Two further parameters involving
`REM sleep were defined in order to
`measure the degree of REM sleep
`fragment:ttion. These were REM sleep
`efficiencies with and without ~tage 2.
`i.e. other patterns of definite sleep. For
`each REM ~deep· period, the number of
`epochs between the lint and the last 40
`sec REM sleep epoch of' that period
`was determim.~d. This was desi.gnatcd
`the "total REM sleep period duration".
`lleeause of fragmentation, it included
`I!JHH;hs of wakefulness, stage I, MT
`and, at time~. stage· 2. REM sleep
`efficiency without stage 2 rd!ors to the
`percentage of the REM ~leep period
`duration consisting of REM sleep
`epochs only. REM sleep efficiency
`inclttding: stage 2 refers to the percen(cid:173)
`tage ofthc REM sleep period dura.tion
`comisti11g of epochs of REM 8leep or
`of stage 2 sleep, i.e., of definite sleep.
`The two REM sleep efficiency values
`were normaiL,cd for each REM sleep
`period, and an overall average mean
`value for each of the nocturnal and
`diurnal recording periods was ob(cid:173)
`taiued. lu this srudy, a !<EM sleep
`epoch had to be ~eparated from the
`closet precedi.ng REM sleep epoch hy
`at least 15 min to he scored as pan of n
`scparulc REM sleep period. The
`number of REM sleep periods per
`night and their cycle duration, i.e., the
`time fmm the onset of one REM sleep
`period to the onset of t.he next period,
`were also calculated.
`A measm·c for determining the
`degree of overall fragmentation of
`
`night sleep wus also developed. We
`calculated lhe number of periods of
`sleep, be
`these NREM, REM, or
`comhinations of the two, which were
`separated from one another by one
`min or mon: <:lf either MT, wakefulness
`or s.tage 1. Depending upon their
`duration, the,~e nocturnal sleep periods
`were put into five cutegories; !5 min or
`less, 16-JO min,. 31-45 min, 46-60 min.
`and greater than 61 min. ln addition.
`we measured the fn:quellC)l of stage
`shirts out of stages 2, 3 and 4
`collectively (i.e., oUl of NREM sleep)
`and out of REM
`The number of
`shifts out of the former was cxpres:~cd
`per IOO min of the £mn of sl.ages 2, ,;
`and 4 per night, and out of the Iutter
`per !00 min of R F.M sleep per night.
`During the daytime portions of the
`rec.ording~, sleep was analysed for the
`duration of stages!., 2, J, 4, REM, and
`MT; and lhG total sleep times including
`and excluding stage I were eak.,ulated
`as above. The number of daytimt' sleep
`periods was also dctennined. A sleep
`period was defined a.> an episode of
`recorded sleep containing at lea~t 3
`min of ~tagcs 2, J, 4 orR EM sleep, and
`preceded and followed by at least 15
`min of wakefulne~s or stage
`l
`(drowsiness). Thcoe sleep period~ were
`divided into 3 grnups, those of J 1-45
`min, of 46-60 min •tnd of more thnn 6!
`min,. corresponding to
`the
`longer
`measures of conso!id.!LICd sleep at
`night.
`In this paper, the 48 hours baseline
`po!ysornnographi•• data for each pa(cid:173)
`tient is compared to dt~ta after 7 to lO
`nights on GHR treatment. The data of
`each patient for each of the two 24
`hour periods before and after G HR
`trearment were averaged before com(cid:173)
`parison. The two tailed Student t test
`was applied to each variable, unless
`otherwise stal<:d.
`
`RESULTS
`The data nhtai.ned using either the
`portable outpatient or the laboratory
`inpat.iem recorditig techniques were
`~imilar. The major diffcrcm:e was in
`the sleep putt•:rns which appeared just
`before sleep onset at ni.ght. The
`inpatient recording> usually ~howed a
`period of more or less sustained
`wnkfulness until sleep onset, which
`was then followed ~hortly by a REM
`
`FEBRUARY !980- 25
`
`

`
`HIE CANi\DIAN JOURNAl. OF NEUROtOOICAL SCIENCES
`
`ProcGH6
`d'
`
`3
`2
`
`Figure l - A 48-hour co!ltinu\ms baseline recording l.n a typical (hospitalized) patient. It illustrates the frequent awakenings during
`nocturnal sleep, multiple sleep onset REM periods, fragmental ion of REM sleep. and other features of ~leep in narcolepS}1-Cataplcxy
`(note: in Figs. I and Z the vertical a~i~ indicates. sleep stages, and thch.oriwmal ax.is the time in hours. REM sleep is shown as a horiwntal
`whitt bar at the level o! stage I, and movement by small triangles abov~: the sleep Htage line. Time zero hours in both figures was
`lO:.J.0-1 1;()0 ll.m.).
`
`43
`
`48
`
`19
`
`2!
`
`l'l'gr.tre 2 --···A 48-hour mwrding nfthe~amc patient on days 9 and 10 of nocturnal G HR. Times of administration am noted by arrows beloW
`the hnrb:ontal a.xis. The figure illusl.ml.es the increased continuity of nocturnal REM sleep. lhe decrca~e in number of nocturnal
`awakenings, and the nduction (If daytime sleep (dc.~pite the subjects having remained quietly in tht: hospital laboratory while un (l H B).
`
`2h- FEBRUARY 1980
`
`GliB and Slet'p/waking Pallt'I"'M in Narcolep.W
`
`[
`
`~)
`{
`
`! ( !
`I
`I f
`~ j
`
`~
`
`f
`
`

`
`LEJOURNA Ci\NADIEN DFS SCIENCES NEI.:FWLOGlQl!ES
`
`Sl
`s:
`(min)
`
`Stage l (min)
`Siagr..M 2
`S!age ] 1 4
`RFM (mini
`
`TABLF .I
`
`GH.R
`
`16. ± 6.1
`1.3
`llli.l ....
`;
`8\1 ()
`7 . .7
`S4.l
`11.0
`9 .. 1 ± l4
`16.0
`7.7
`
`li.O
`5.9
`I.J
`2.7
`I
`_._ 1
`09:t
`L2 ±I
`
`·······················
`
`..........
`
`TABLE l
`
`llasdhw
`
`CUB
`
`50.2
`69 8 ± 47 3
`IH.9 ± !6.6
`l ± 21
`9.9
`I 1.6
`19.5
`
`S2
`
`Slg.
`
`.005
`
`005
`
`.02.'5
`
`Slg,
`
`.015
`
`.005
`.01
`
`

`
`THE CANADIAN JOURNAL OF NElJROLOGICAL SCIENCES
`
`of this, although the total sleep time
`(including stage I patterns of drowsi(cid:173)
`ness) during the duy remained un·
`changed, <tctual sleep (excluding stage
`!) was decreased and the individual
`daytime sleep pcriQds became &hortcr.
`The overall major cffl:ct of the drug,
`then, was to impr<1VC the c<mtitwily of
`not:t.urnal :deep and to reduce long
`periods of daytime sleep and diurnal
`slow wave and REM sleep. Subjective(cid:173)
`ly. the daytime sleep was pcrccivc:d as
`being less imperative.
`finally, although there is evidence
`that GH B can produce EEG and
`behavioral manife-stations similar to
`petit mal epilepsy in rats (GodM:halk et
`aL, 1977) and in cats (Snead ct al.,
`1976), no potentially epileptogenic
`EEG dischurgcs were present in these
`very J>to!ongcd recordings or in later
`follow-up recordings, and no dink-a]
`~ci:r.un:~ have occurred ..
`
`DISCUSSION
`The clinical and polysomnographk
`changes produced by GHB during the
`7- J0 d!l)' J)Criod followed ll parallel
`COUI'SC. Cliniclllly, as previously re-
`ported (Broughton and Mamelak,
`1979), there was reduction both in the
`duration of duytime >leep and in the
`incidencc ar1tl intensity of cataplectic
`attat:ks; and, corresponding to tl1is, the
`daytime portions of polygraphic re-
`eordlngs showed less actual total sleep
`lime, and less time in ~low wave sleep
`and in REM sk'!!.'P· Subjective drows)..
`to be a
`ness, howev•:•·, continued
`pmblem. It was ref1ected in the lad; of
`any significant change in daytime ~tage
`I sleep. which in fact was somewhat
`increased. (Drowsin,c.s~ was subs.e-
`quently improved with methyl-pheni-
`date.) Night sleep was perceived as
`being de~eper and less restles&. There
`was loss of nightmares and hai.lucina-
`tions, although dreaming, in a more
`pleasant manner, continued. Corrcs-
`pondl ngly, the nighttime portion of
`the re<:onlings showed lhat sleep was
`consolidatt:d into longer periods, there
`were fewer stage shifts and sleep,
`particularly REM sleep, was more
`integrated <md less fragmented. Al-
`though sleep <m~ct REM periods still
`occurred, 1md in fact were even more
`frequent on GHR, these differed fmm
`
`sleep period (Fig. IJ. Patients recorded
`at home tended to d_rift from wakeful·
`ness in and out of brief 1-3 rrJin periods
`of REM ~d<>ep or stage I for scvcml
`minutes or even dozens of minutes,
`before f11lling into a consolidated sleep
`period of at least 10 min; and tll<.'Jl
`usually thcfl had much longer or even
`normal REM sleep latencies~ The
`REM sleep latencies recorded in the
`outpatient sltldies wert: thus signifi(cid:173)
`cantly longer than in the inpatient
`studie~ (Chi squared test, p < 0.005)~
`Other REM sleep measures did ll()t
`differ signific<mtly between the two
`laboratories.
`rhc nocturnal pre-G HB baseline
`recordings (Table I) showed a number
`of features when compared to pub(cid:173)
`lished data (Williams L:l at., 1974}, and
`confirmed the findings of other:s for
`thi~ condition ( Rechtschaffen ei ;ll.,
`1962; Harms-Ferreira and Lairy, 1976;
`1978). Thest:
`Montplaisir et a!.,
`included early or direct sleep 011set
`REM periods, frequent awnkenings
`and period~ of relatively prolonged
`low sleep efficiencies.
`wakefulncs.s,
`and frequent stage shifts. In short,
`sleep was characterized by
`night
`marked fragmentation. which was also
`in our mc<tsures showing
`reflected
`frequent short (i ,e., 15 min or less)
`periods of sleep and low REM sleep
`efficiencies (with and without stnge 2).
`The daytime sleep measures before
`Gi-l B arc given in Table 2. Fig. l shows
`a 48-hour pre~GHB recording in a
`typical patient.
`GHB (Table t, Fig. 2) significantly
`increased the dm-alion ()f nocturnal
`slow wave sleep at !:he cxp!:nse ofstage
`sleep eff1ciency
`the
`I,
`increase<i
`measures. nnd decreased the number
`of sleep periods less than 15 min in
`duration. The total amount of REI-1
`~leep was unchanged, hut it bcc<lmc
`indicated by
`fragmented, as
`less
`significantly fewer stage shift~ out of
`REM sleep and by an increase in the
`REM sleep efficiency. GHB signifi(cid:173)
`cantly decreased both the latency to
`REM ~leep and the density ofthe rapid
`eye movements themselves. The day(cid:173)
`time data (Table 2) indicated that
`nocturnal GHB resulted in a signifi(cid:173)
`cunt decrease in the durution of both
`diurnal slow wave sleep and REM
`! patterns, however,
`sleep. St:agc
`increased (non-significantly). Hec:au~e
`
`2!1- FEliRU/\.RY 1980
`
`..
`...
`
`[
`t
`( I
`r l
`
`'~
`
`f·
`
`1;
`(·~
`
`~

`
`''l
`
`··_
`
`:1~·
`
`that they were not frightening, they
`never reached halludnatory intensity~
`control over mentation was lo~t rather
`thun mnintaincd, and the presence of
`concomit<Hif <1warencs.s of ones' sm·.
`roundings, whid1 <:an occur in thi;;
`C\'mdition ( Hishikawa, 1976; Vogel
`!976), was no longer pre>ent.
`Like other investigator~ surh as Bar(cid:173)
`ros~Fcniera and Lairy ( !976) and
`Montplaisir and colleagues ( 1978), we
`were imprcsol:d by ihe marked di~soci­
`ation and fragmentation of nocturnal
`(and diurnal) sleep whit:h we found in
`our patients' baseline recordings. In
`addition to frequent sleep onset REM
`sleep periods, thl:re were numerous
`qwchs of "intermediate sleep" (i.e"
`simultaneous features (Jf stugc: 2 and
`REM sleep), multiple brief sleep frag ..
`ment~ a.nd prok•nged periods with
`mixed features cof sb.:p and wakefui(cid:173)
`ness. Sleep and it• subcomponents ap(cid:173)
`t.o have become dispersed
`peared
`aro11 nd I. he 24 hours and the barriers
`between sleep and wakefulncs.s to have
`been breached, as exemplified hoth by
`the chronic davtim1: drowsiness and
`the wakeful awareness during po.ly-
`graphically monitored REM sleep,
`especially at sleep onset.
`GHR tended to reverse these rea-
`tun:~. lt I>YDduced increased mnsolid-
`ation and re-integration of ~!eep and
`increasingly synchroniJ~cd sleep with
`the nocturnal period. Each dnse
`<u;sured a 2 to 3 hour period of steep at
`uhoul the same time cad1~ night. In
`each of these periods, REM ~leep
`usually oc.curn:d at sleep onset and was
`followed by a period of ~;low wave
`rc·
`the
`(Fig. 2). Although
`slt:cp
`nnrmnlit.at.ion of night sleep clearly
`therefore not complete, each
`was
`period of drug·i:nduct~d sleep consisted
`of sleep which w<ts more continuous,
`having fr'lrT.r awakenings and fewt:~·
`stage shifts. The subjective assessment
`of patients on medication was tlH't
`they were truly asleep during each two
`three hour drug-induced sleep
`to
`period agd did not experience "twi·
`light" states of mixed sleep and
`wakefulness. Although the total dun.\·
`tion per se of nocturnal sleep was not
`incrca~cd by GHB., the drug's nocHH..
`nal d'fC;cts did alter the duratiNI and
`organization Df daytime sleep. There
`was significant decrease in the dura-
`tion of both REM sleep and ~low wave...· ... ··~ •I.
`
`their pre-treatment cnunterparts
`
`in
`
`G Jill ami Sleep f wakil'lg Pal/ems in Nat<"o/eJMY ...I
`
`

`
`LEJOURNALCANADIEN DES SCIENCES NEUROLOGIQUES
`
`sleep during the d;iy and the individual
`~Jeep periods became shorter and more
`fragmented. This effect might have
`been more impressive statLstieally, had
`not half our patlents (the Toronto
`inpatients) remained in bed during the
`day.
`\Vhi!c on the drug our patients
`reported that, although they were still
`drowsy and even slept during the day,
`thev wen: now better able to resist
`r!c~p and could ~tay &w<dte, when this
`was necessary. Before starting treat(cid:173)
`ment they averaged about 9 to !0
`hours of sleep in a 24 hour period (of
`which 6 to 7 hours occurred at night),
`Thes!: total figures, which were not
`t:ha nged much by G HI~ treatment, are
`not very different from those recorded
`in ad lib sleep of normals, who will also
`sleep for about 10 to ! 2 hours in a 24
`hour period. when freely permitted to
`do so (Hishikawa et aL 1976). Yet.
`under most circumstances, normals
`remain fully awake during the day with
`S(tVen to eight hours of sleep at night or
`even
`less
`(\'./ebb and Cartwright,
`!978). What make:;
`this pattern
`possible for them but not for narcolep(cid:173)
`tics'! We suggest that it is because the
`night
`sleep of normals
`is more
`\ll
`int(:grutcd
`than
`is
`tlw
`sleep
`narcoleptics. That is. in normal ~leep
`the component suhsystems run their
`cour~e for the most part in seven to
`eight conl!ecutive hours usually syn(cid:173)
`chronin:d with the nocturnal period.
`In narcoleptic sleep, on the othCI" hand,
`the di:~sociati<'m and temporal disper(cid:173)
`sion of the ~leep sub~components
`prevents this and leads to daytime
`occurrence of sleep or of chronic
`drowsiness -- a mixture of sleep and
`wakefulness. At the same time, the
`is
`nighttime sleep of nan:olcptics
`rendered shallow and fragmented and
`loses its stable circadian pattern of
`deep NRilM s.!eep concentrated in the
`first third of the nighL
`It is our thesis that the 6 to 7 hours of
`sleep facilitated by G I-IH has greater
`circadian ~tabilily und is a more fullv
`i.ntegrated sleep-, especially of the
`REM sleep state, than is that which
`occurs in narcoleptics in the absence of
`the drug. As evidence, we can cite the
`drug-induced decrease in the number
`of nocturnal sleep stage shifts. as well
`<is the overall improvement in sleep
`efficiency nt night. Nocturnal GHB
`
`appears 1 o "glue" together the c:om(cid:173)
`poncnt subsystems of sleep and to
`impede
`their
`temporal dispcr;;ion
`around the 24-h(HII'S. As a result,
`daytime sleep become~ less consolid(cid:173)
`ated, with stage I sleep, i.e, drowsi(cid:173)
`ness, increalling at the expense ofslow
`wave sleep ;md REM sleep.
`!'his
`ac.counts for the patients' subjective
`imprc:~sion tlml the:~ are better able 1.0
`re~l:~t ~lceping during the day on GHB.
`When small divided doses (Stu 10 rng
`Li.d.) of methylphenidate weJe later
`added to the drug regimen during t.he
`day, diurnal sleep and drowsiness
`virtually disappeared in many patients
`(Broughton and l'vfamelak, 1979). lt
`can be <Juestioned whether me1hyl~
`phenidate would be neces-'<ary ~tl all, if
`the duration of action of GHB c;ould
`he extended l<:l' integrate sleep at night
`for a full seven to eight hours.
`The decrease in the frequency and
`intensity of cataplectic attacks is one of
`the earliest and most
`impressive
`clinical benefits of GHB treatment As
`the duration of' the direct action of
`GHB (Mamelak et uL, 1977) and its
`detectable presence
`in
`the blood
`(Belrich et aL, 1964) lasl nnly some
`2. 5-.3.0 hours, the dayt !me. changes
`must be '~"plaincd mainly or only by
`noctumal cfl'ecb. when the substance
`h given. Again, it is :mggcstcd that. t.hi8
`re~ults from
`the nocturnal skcp
`integrating and synchronizing actions
`of the drug. Cataplexy has been
`attributed to the dissociated selective
`aclivati nn nf thL: motor inhibitory
`eomponent of REM sleep (Dement ct
`a!., 1976). Our data indicate that
`nocturnal GHH significantly decreases
`the total amount of REM sleep during
`the day: the dec!im; in the number of
`diurnal cataplectic attacks may be due
`to thiN, Other studies, moreover, have
`shown that daytime administration uf
`GHB in nan:olepsy-cataplexy has the
`apparently unique effect of heing ahle
`to induce sleep paralysis (!VIame!ak e1
`al., 1977). This suggests
`that,
`in
`addition to its facilitating or activating
`effe<:t on REM slee1' per ~c. the drug
`c:an also selectively activate th<.: motor
`inhibitory component of th1: REM
`sleep state
`in
`such patients. The
`sensitivity of this motor process to
`GHR was further demonstrated re(cid:173)
`cently by 1\hmnlek, Sowden and
`Curuso (in press) in studic~ on the
`
`Broughton & l'•'mrwlak
`
`L_
`
`effect of this drt1g on monosynaptic
`tran:~misNion in the spinal conj, using
`the H·rclkx technique, Monosynaptic
`transmis:;ion in known to be suppress(cid:173)
`ed during REM sleep (Hnd<;~ and
`Dement, 1964: Hishikawa. and Kaneko,
`1965) as part of the motor inhibitory
`process during this sleep state (1-'mn(cid:173)
`peiano, 1976)_ nut
`the studies of
`Mamelak, Sowden, and Caruso (in
`press) show that with G H B morwsyn(cid:173)
`a.ptk transmission is blocked dming
`borh REM and slow wave otatcs
`l'oll.<lwing drug <tdministrut inn. Since a
`refractory period occurs afler REM
`sleep (Jouvet. 1962; Pompeiano, !976),
`an analogous state may also prevail
`after the iS(l[atcd activation of thc
`motor !nhibiiory pwccss. The ameli(cid:173)
`oration of daytime cataplexy may be
`related in this W<IY to prolonged noc(cid:173)
`turnal activation by the drug of !he
`motor inhibitory mechanisms of REM
`sleep.,
`Why do ordinary hypnotic drugs
`11ot benefit narcoleptic patients'? It
`should be noted first that at times they
`can do !>O, Many n<trcok:ptic patients
`use such drugs at night to tmf>mve
`!.heir sleep and obtain eon,identhl~
`relief from
`their diurnal ~ymptom>
`(IJunicls, 1934; Zarcone, 1973). Bt.~­
`causc of their lung duration or action,
`however, tlu:se drugs may increase
`daytime drow~oiness (Daniels, 19.34);
`and, in addiuon, lheir consolidating
`cff(a;ts on nighttime sleep tend to wane
`tolerance develops_ Moreover,
`!IS
`ordinary hypnotic drugs often sup(cid:173)
`press both REM slcer' and slow wave
`sleetl, and can create incrcuscd pres(cid:173)
`sure, a1 least for REM sleep, later in
`the night as the drugs wear off (Kales ct
`a!., 1970). GH.B hilS none of these
`disaclvaniagcs. lt io rnpi.dly rnetubo(cid:173)
`Iiz.ed and iN deared rmm the blqod
`two
`three hours
`stream after
`lo
`(Helrich el at; 1964), tolerance fails to
`develop lo its hypnotic effect (Vickers,
`1969), and most import:::~nt, it does nol
`appear to suppress either REM sleep
`or slow wav(: sleep or sub-components
`of them_ ln fact, in direct contrast to
`the synthetic hypnotics, it generally
`increases the duration of slow wave
`sleep and
`facilitates REM
`sleep
`(Mamc!ak. ct aL, 1977).
`It must be emphasized, however,.
`that
`the
`increase
`in ddta activitv
`pnxh1ccd by GHB may not represent it
`
`FEBRUARY 1980-29
`
`

`
`THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
`
`true increase in physiological slow
`wave sl<~l:p. G Hl3 can paradoxically
`induce della activity witb the subject
`either awake or asleep (Metcalfe cl aL,
`966; Yamad<t ct al., !967). Thcover~ll
`increase in delta activity recorded In
`our subjects may therefore represent a
`drug eflht. rather than an increase of
`physiological ~low wave >!ccp. REM
`sleep facilitation
`is a more certain
`property of the drug .. Not only were the
`psychological attributes of G H B(cid:173)
`induced REM sleep simihu to those of
`natundly oceurriog REM sle.ep, but its
`poly~omnographic and motor charac(cid:173)
`teristics are similar as weU (Mamelak
`et aL, !977; Mamelak, Sowden, and
`Caruso (in press). For these reasons, it
`is int

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket